Related Experiment Video
Updated: Jul 1, 2025

07:35
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
1.6K
HKFGCN: A novel multiple kernel fusion framework on graph convolutional network to predict microbe-drug associations
Ziyu Wu1, Shasha Li2, Lingyun Luo3
1School of Computer Science, University of South China, Hengyang, Hunan 421001, China.
Computational Biology and Chemistry
|March 12, 2024
Summary
This study introduces HKFGCN, a computational method to predict microbe-drug associations. This approach enhances drug discovery efficiency by analyzing microbial interactions and drug targets, reducing experimental costs.
Area of Science:
- Microbiology
- Pharmacology
- Computational Biology
Background:
- Human microbes interact with hosts, regulating drug effectiveness.
- Microbe-drug associations are crucial for drug discovery and antimicrobial development.
- Experimental identification of microbe-drug links is time-consuming and costly.
Purpose of the Study:
- To develop an efficient computational method for predicting microbe-drug associations.
- To reduce the cost and time associated with experimental identification.
- To provide a new computational tool for drug discovery.
Main Methods:
- Developed HKFGCN (Heterogeneous information Kernel Fusion Graph Convolution Network).
- Constructed microbe-drug association networks and similarity networks.
- Extracted topological and Gaussian kernel features from multiple networks.
- Reconstructed bipartite microbe-drug graphs using learned representations.
Main Results:
- HKFGCN demonstrated excellent performance across various datasets.
- The model achieved high accuracy in predicting microbe-drug associations.
- Case studies, including HIV, showed results consistent with existing literature.
Conclusions:
- HKFGCN is a promising computational method for predicting microbe-drug associations.
- The model offers a cost-effective and efficient alternative to experimental methods.
- This approach can accelerate drug discovery and development by identifying novel microbe-drug links.

